Lung Cancer, policy, lung cancer policies, improving lung cancer outcomes, addressing awareness, availability and access in lung cancer
NSCLC, TP53, biomarker, targeted therapy, brain metastases
Small Cell Lung Carcinoma, Lung Neoplasms, Retrospective Studies, Cranial Irradiation
Metastasis, performance status, disease burden, overall survival, targeted therapies
docetaxel, immunotherapy, real-world evidence, NSCLC